Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa

dc.contributor.authorKim, Young E.
dc.contributor.authorSicuri, Elisa
dc.contributor.authorTediosi, Fabrizio
dc.date.accessioned2016-02-03T09:19:30Z
dc.date.available2016-02-03T09:19:30Z
dc.date.issued2015-09-11
dc.date.updated2016-02-02T15:33:39Z
dc.description.abstractBACKGROUND: Onchocerciasis (river blindness) is a parasitic disease transmitted by blackflies. Symptoms include severe itching, skin lesions, and vision impairment including blindness. More than 99% of all cases are concentrated in sub-Saharan Africa. Fortunately, vector control and community-directed treatment with ivermectin have significantly decreased morbidity, and the treatment goal is shifting from control to elimination in Africa. METHODS: We estimated financial resources and societal opportunity costs associated with scaling up community-directed treatment with ivermectin and implementing surveillance and response systems in endemic African regions for alternative treatment goals-control, elimination, and eradication. We used a micro-costing approach that allows adjustment for time-variant resource utilization and for the heterogeneity in the demographic, epidemiological, and political situation. RESULTS: The elimination and eradication scenarios, which include scaling up treatments to hypo-endemic and operationally challenging areas at the latest by 2021 and implementing intensive surveillance, would allow savings of $1.5 billion and $1.6 billion over 2013-2045 as compared to the control scenario. Although the elimination and eradication scenarios would require higher surveillance costs ($215 million and $242 million) than the control scenario ($47 million), intensive surveillance would enable treatments to be safely stopped earlier, thereby saving unnecessary costs for prolonged treatments as in the control scenario lacking such surveillance and response systems. CONCLUSIONS: The elimination and eradication of onchocerciasis are predicted to allow substantial cost-savings in the long run. To realize cost-savings, policymakers should keep empowering community volunteers, and pharmaceutical companies would need to continue drug donation. To sustain high surveillance costs required for elimination and eradication, endemic countries would need to enhance their domestic funding capacity. Societal and political will would be critical to sustaining all of these efforts in the long term.
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1935-2727
dc.identifier.pmid26360917
dc.identifier.urihttps://hdl.handle.net/2445/69171
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1371/journal.pntd.0004056
dc.relation.ispartofPLoS Neglected Tropical Diseases, 2015, vol. 9, num. 9, p. e0004056
dc.relation.urihttp://dx.doi.org/10.1371/journal.pntd.0004056
dc.rightscc by (c) Kim et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationMalalties parasitàries
dc.subject.classificationEpidemiologia
dc.subject.classificationÀfrica subsahariana
dc.subject.classificationAnàlisi econòmica
dc.subject.classificationOncocercosi
dc.subject.otherParasitic diseases
dc.subject.otherEpidemiology
dc.subject.otherSub-Saharan Africa
dc.subject.otherEconomic analysis
dc.subject.otherOnchocerciasis
dc.titleFinancial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
kim2015_1982.pdf
Mida:
1.94 MB
Format:
Adobe Portable Document Format